A Novel beta-lactam/beta-lactamase Inhibitor: Ceftolozane/tazobactam

dc.contributor.author	Serefhanoglu, Kivanc
dc.date.accessioned	2021-12-21T08:45:32Z
dc.date.available	2021-12-21T08:45:32Z
dc.date.issued	2019
dc.identifier.issn	2147-673X
dc.identifier.uri	https://doi.org/10.4274/mjima.galenos.2019.2019.10
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1612
dc.description.abstract	Ceftolozane/tazobactam is a novel generation cephalosporin and p-lactamase inhibitor combination antibiotic. It was approved for the treatment of adults (18 years and older) with complicated intraabdominal infections used in combination with metronidazole
dc.language.iso	English
dc.publisher	Galenos Yayıncılık
dc.rights	gold
dc.title	A Novel beta-lactam/beta-lactamase Inhibitor: Ceftolozane/tazobactam
dc.type	Review
dc.relation.journal	Medıterranean Journal Of Infectıon Mıcrobes And Antımıcrobıals
dc.identifier.volume	8
dc.identifier.doi	10.4274/mjima.galenos.2019.2019.10
dc.relation.volume	8

Files in this item

Files	Size	Format	View
There are no files associated with this item.